Skip to content

Author

M. Horani

We have 2 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Treatment Outcomes of Patients with Early-Stage Breast Cancer Meeting NATALEE Eligibility Criteria. A Real-World Cohort Study

The findings provide real-world historical outcome data for patients who would now be considered candidates for adjuvant ribociclib and may serve as a benchmark for evaluating outcomes following adoption of adjuvant ribociclib.

H. Abdel-Razeq, M. Horani, F. Tamimi et al. · 0 citations
Open access Jul 2026

Landscape of germline genetic alterations among non-western young male patients with cancer. Findings from The Jordanian exploratory cancer genetics study

Germline P/LP variants are common in young male patients with cancer, particularly at younger ages and among those meeting testing criteria, and these findings support broader implementation of germline testing to inform management and familial risk assessment.

H. Abdel-Razeq, Hira Bani Hani, Seif Alafeef et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.